These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20075953)

  • 21. Hepatitis B virus infection and vaccination in children undergoing hemodialysis.
    Callis LM; Clanxet J; Fortuny G; Caballeria J; Carrasco JL; Lardinois R
    Acta Paediatr Scand; 1985 Mar; 74(2):213-8. PubMed ID: 3993367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients.
    Tong NK; Beran J; Kee SA; Miguel JL; Sánchez C; Bayas JM; Vilella A; de Juanes JR; Arrazola P; Calbo-Torrecillas F; de Novales EL; Hamtiaux V; Lievens M; Stoffel M
    Kidney Int; 2005 Nov; 68(5):2298-303. PubMed ID: 16221232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed.
    Prescrire Int; 2008 Dec; 17(98):234-6. PubMed ID: 19422145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
    Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
    East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National surveillance of dialysis-associated diseases in the United States, 2002.
    Finelli L; Miller JT; Tokars JI; Alter MJ; Arduino MJ
    Semin Dial; 2005; 18(1):52-61. PubMed ID: 15663766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine.
    Shouval D; Roggendorf H; Roggendorf M
    Med Microbiol Immunol; 2015 Feb; 204(1):57-68. PubMed ID: 25557605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extra-high-dose hepatitis B vaccination does not confer longer serological protection in peritoneal dialysis patients: a randomized controlled trial.
    Chow KM; Lo SH; Szeto CC; Yuen SK; Wong KS; Kwan BC; Leung CB; Li PK
    Nephrol Dial Transplant; 2010 Jul; 25(7):2303-9. PubMed ID: 20185409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
    Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
    Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing Hepatitis B in the Dialysis Unit.
    Soi V; Soman S
    Adv Chronic Kidney Dis; 2019 May; 26(3):179-184. PubMed ID: 31202390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B vaccine as a cause of false positive hepatitis B surface antigen.
    Olde C; Garcia M
    J CANNT; 1998; 8(4):20-1. PubMed ID: 10196927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules.
    McNulty CA; Bowen JK; Williams AJ
    Vaccine; 2005 Jul; 23(32):4142-7. PubMed ID: 15913854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B surface antigenemia following recombinant Engerix B hepatitis B vaccine in an 81-year-old ESRD patient on hemodialysis.
    Onuigbo MA; Nesbit A; Weisenbeck J; Hurlburt J
    Ren Fail; 2010 May; 32(4):531-2. PubMed ID: 20446799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
    Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
    Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The decades-long fight against HBV transmission to dialysis patients: slow but definite progress.
    Labriola L; Jadoul M
    Nephrol Dial Transplant; 2010 Jul; 25(7):2047-9. PubMed ID: 20466682
    [No Abstract]   [Full Text] [Related]  

  • 36. Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease.
    Fabrizi F; Dixit V; Magnini M; Elli A; Martin P
    Aliment Pharmacol Ther; 2006 Aug; 24(3):497-506. PubMed ID: 16886915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus infection and the dialysis patient.
    Fabrizi F; Messa P; Martin P
    Semin Dial; 2008; 21(5):440-6. PubMed ID: 18397202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National surveillance of dialysis associated diseases in the United States, 1992.
    Tokars JI; Alter MJ; Favero MS; Moyer LA; Miller E; Bland LA
    ASAIO J; 1994; 40(4):1020-31. PubMed ID: 7858322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis B in chronic kidney disease: moving toward effective prevention.
    Unger JK; Peters H
    Kidney Int; 2008 Apr; 73(7):799-801. PubMed ID: 18340351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved hepatitis B vaccination rates in ESRD patients in California.
    Brown J; Peters V
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S95-9. PubMed ID: 11053594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.